Hyperechogenic Bowel: Etiologies, Management, and Outcome according to Gestational Age at Diagnosis in 279 Consecutive Cases in a Single Center

Abstract

Introduction The aim of the study was to investigate perinatal outcome of fetuses with hyperechogenic bowel (HB) in relation to gestational age at diagnosis.

Materials and Methods This is a retrospective observational study of fetal HB cases from 2002 to 2012. Patients were divided into three groups according to trimester at diagnosis. For each group, data from fetal ultrasound examination, fetal medicine investigations, intrapartum cares, and neonatal outcome were obtained.

Results A diagnosis of HB was made in 279 fetuses among them 17 (6%) during the first trimester, 186 (67%) during the second trimester, and 75 (27%) during the third trimester. A significant prevalence of maternal comorbidities was noticed in group 1 (12%: p = 0.02). A chromosomal defect was identified in 13% of the fetuses without difference among the three groups. HB was associated with prenatal infection in 11.5% (n = 32) of the cases, with an equal distribution between groups 2 and 3. Intrauterine growth retardation was noticed in 23% (n = 64) of the cases with a slightly high prevalence in groups 1 (35%). HB was the only ultrasonographic intestinal soft marker in 80% (n = 223) of the fetuses, two-third of them were detected during the first and the second trimesters (p = 0.001). However, HB was associated with bowel dilation in 33% of the cases diagnosed during the third trimester (p = 001). Ultrasonographic extraintestinal anomalies were identified in 30% of the fetuses with a higher prevalence in group 1 (59%). HB resolved spontaneously in 55 (19.7%) cases—without difference among the three groups. In group 1 we recorded a significant prevalence of intrauterine demise (23.5%, p = 0.004). Two hundred twenty-seven (81.3%) pregnancies resulted in live-born neonates; among them gastrointestinal anomalies were noticed in 12.5% with a significant prevalence in group 3 (36%) compared with 6 and 5.4% in groups 1 and 2, respectively (p = 0.001). Extraintestinal anomalies were confirmed in 27% of the cases, whereas postnatal mortality rate was of 7% without differences between the three groups.

Conclusion Detection of HB during the first trimester is associated with an increased risk for maternal comorbidities, intrauterine growth retardation, and adverse pregnancy outcome. Moreover, if HB is detected during the second trimester, it is associated with a favorable prognosis. Otherwise, HB detected during the third trimester is associated with a significant risk of gastrointestinal anomaly.

Keywords

hyperechogenic bowel - gestational age - outcome - intestinal malformation

• References

• 1 Saha E, Mullins EW, Paramasivam G, Kumar S, Lakasing L. Perinatal outcomes of fetal echogenic bowel. Prenat Diagn 2012; 32 (8) 758-764
• 2 Nyberg DA, Dubinsky T, Resta RG, Mahony BS, Hickok DE, Luthy DA. Echogenic fetal bowel during the second trimester: clinical importance. Radiology 1993; 188 (2) 527-531
• 3 Dicke JM, Crane JP. Sonographically detected hyperechoic fetal bowel: significance and implications for pregnancy management. Obstet Gynecol 1992; 80 (5) 778-782
• 4 De Oronzo MA. Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome?. J Prenat Med 2011; 5 (1) 9-13
• 5 Ghose I, Mason GC, Martinez D , et al. Hyperechogenic fetal bowel: a prospective analysis of sixty consecutive cases. BJOG 2000; 107 (3) 426-429
• 6 Goetzinger KR, Cahill AG, Macones GA, Odibo AO. Echogenic bowel on second-trimester ultrasonography: evaluating the risk of adverse pregnancy outcome. Obstet Gynecol 2011; 117 (6) 1341-1348
• 7 Penna L, Bower S. Hyperechogenic bowel in the second trimester fetus: a review. Prenat Diagn 2000; 20 (11) 909-913
• 8 Hill LM, Fries J, Hecker J, Grzybek P. Second-trimester echogenic small bowel: an increased risk for adverse perinatal outcome. Prenat Diagn 1994; 14 (9) 845-850
• 9 Mailath-Pokorny M, Klein K, Klebermass-Schrehof K, Hachemian N, Bettelheim D. Are fetuses with isolated echogenic bowel at higher risk for an adverse pregnancy outcome? Experiences from a tertiary referral center. Prenat Diagn 2012; 32 (13) 1295-1299
• 10 Slotnick RN, Abuhamad AZ. Prognostic implications of fetal echogenic bowel. Lancet 1996; 347 (8994): 85-87
• 11 Strocker AM, Snijders RJ, Carlson DE , et al. Fetal echogenic bowel: parameters to be considered in differential diagnosis. Ultrasound Obstet Gynecol 2000; 16 (6) 519-523
• 12 Vintzileos AM, Egan JF. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol 1995; 172 (3) 837-844
• 13 Yaron Y, Hassan S, Geva E, Kupferminc MJ, Yavetz H, Evans MI. Evaluation of fetal echogenic bowel in the second trimester. Fetal Diagn Ther 1999; 14 (3) 176-180
• 14 Bromley B, Doubilet P, Frigoletto Jr FD, Krauss C, Estroff JA, Benacerraf BR. Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis?. Obstet Gynecol 1994; 83 (5 Pt 1): 647-651
• 15 Scioscia AL, Pretorius DH, Budorick NE, Cahill TC, Axelrod FT, Leopold GR. Second-trimester echogenic bowel and chromosomal abnormalities. Am J Obstet Gynecol 1992; 167 (4 Pt 1): 889-894
• 16 Monaghan KG, Feldman GL. The risk of cystic fibrosis with prenatally detected echogenic bowel in an ethnically and racially diverse North American population. Prenat Diagn 1999; 19 (7) 604-609
• 17 SIEOG Available at: http://www.sieog.it/linee-guida/2015 . Accessed December 13, 2016
• 18 Muller F, Dommergues M, Aubry MC , et al. Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome. Am J Obstet Gynecol 1995; 173 (2) 508-513
• 19 Sepulveda W, Sebire NJ. Fetal echogenic bowel: a complex scenario. Ultrasound Obstet Gynecol 2000; 16 (6) 510-514
• 20 Buiter HD, Holswilder-Olde Scholtenhuis MA, Bouman K, van Baren R, Bilardo CM, Bos AF. Outcome of infants presenting with echogenic bowel in the second trimester of pregnancy. Arch Dis Child Fetal Neonatal Ed 2013; 98 (3) F256-F259
• 21 Ruiz MJ, Thatch KA, Fisher JC, Simpson LL, Cowles RA. Neonatal outcomes associated with intestinal abnormalities diagnosed by fetal ultrasound. J Pediatr Surg 2009; 44 (1) 71-74 , discussion 74–75
• 22 Al-Kouatly HB, Chasen ST, Streltzoff J, Chervenak FA. The clinical significance of fetal echogenic bowel. Am J Obstet Gynecol 2001; 185 (5) 1035-1038
• 23 Sipes SL, Weiner CP, Wenstrom KD, Williamson RA, Grant SS, Mueller GM. Fetal echogenic bowel on ultrasound: is there clinical significance?. Fetal Diagn Ther 1994; 9 (1) 38-43
• 24 Corteville JE, Gray DL, Langer JC. Bowel abnormalities in the fetus—correlation of prenatal ultrasonographic findings with outcome. Am J Obstet Gynecol 1996; 175 (3 Pt 1): 724-729
• 25 Wax JR, Hamilton T, Cartin A, Dudley J, Pinette MG, Blackstone J. Congenital jejunal and ileal atresia: natural prenatal sonographic history and association with neonatal outcome. J Ultrasound Med 2006; 25 (3) 337-342
• 26 Bashiri A, Burstein E, Hershkowitz R, Maor E, Landau D, Mazor M. Fetal echogenic bowel at 17 weeks' gestational age as the early and only sign of a very long segment of Hirschsprung disease. J Ultrasound Med 2008; 27 (7) 1125-1126